mRNA Stock Today - Search News

Agrees to review Moderna flu vaccine

Moderna jumps above 20-day moving average on FDA flu vaccine review. Should you buy MRNA stock here?

Moderna (MRNA) stock closed higher on Wednesday after the FDA reversed its earlier refusal-to-file decision on the company’s mRNA-1010 seasonal influenza vaccine. As the regulatory agency agreed to review MRNA’s revised application,

Stocktwits on MSN · 12h

Moderna stock gains after FDA accepts company’s revised flu vaccine application for review

· 9h

FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars

· 12h

FDA Reverses Course and Will Now Review Moderna’s Flu Shot

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA 4.03% application to sell a new seasonal flu shot after the vaccine maker agreed to conduct additional t...

· 13h

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

· 4h

US FDA reverses course, will review Moderna's flu vaccine application

Schaeffer's Investment Research

Moderna Stock Pops as FDA Application Moves Forward

Moderna (MRNA) stock is on the rise after the U.S. Food & Drug Administration (FDA) accepted the company's flu vaccine application for review

How to Buy Moderna Stock (MRNA) in 2026

Moderna is a well-known biotech company from its pandemic success. Here's what investors should know about its growth story now.

Why Moderna Stock Just Popped

Vaccine specialist Moderna (NASDAQ: MRNA) stock soared 5.5% through 12:55 p.m. ET Wednesday after The Wall Street Journal reported that the U.S. Food and Drug Administration will accept (note: "accept," but not automatically "approve") Moderna's application to sell a new seasonal flu shot good for the 2026-2027 flu season.

Blockonomi

Moderna (MRNA) Stock Slips Despite Beating Q4 Revenue and Earnings Estimates

Moderna (MRNA) stock fell 0.3% Friday despite beating Q4 revenue estimates at $678M and posting narrower loss of $2.11/share after FDA rejected flu vaccine review.

5don MSN

4 stocks to watch on Friday: MRNA, TWLO, ANET, LLY

Stock index futures were little changed on Friday as traders awaited key retail inflation data due out ahead of the opening bell. Here are the four stocks to watch on the day: Moderna (MRNA) rose 0.2% in premarket trading after reporting better-than-expected Q4 2025 financials on Friday.